Condition: Psychosis · Schizophrenia · Schizoaffective Disorder · Sponsor: Mclean Hospital
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is: • Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis? Participants will either: * Receive care as usual (CSC) or * Receive care as usual (CSC) plus five additional care elements (CSC 2.0): 1. Individual peer support 2. Digital outreach 3. Care coordination 4. Multi-family group therapy 5. Cognitive remediation Researchers will compare the standard of care (CSC) to CSC 2.0 to see if participants receiving CSC 2.0 have more visits to their clinic in their first year.
This description comes directly from the study's public registry record.
Dost Ongur, MD, PhD · 617-855-3922 · dongur@mgb.org
Jacqueline Dow, MPH · 617-855-3321 · jdow@mclean.harvard.edu
Always discuss trial participation with your own doctor first.
| McLean Hospital OnTrack Clinic | Belmont, Massachusetts, United States | Recruiting |
| Massachusetts General Hospital FEPP Clinic | Boston, Massachusetts, United States | Recruiting |
| Boston Medical Center WRAP | Boston, Massachusetts, United States | Recruiting |
| Cambridge Health Alliance RISE Clinic | Cambridge, Massachusetts, United States | Recruiting |
| UMass Memorial Community Healthlink STEP Clinic | Worcester, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06071858